News for dentistry professionals
10 Jul 2019
In addition, they must be instructed on how to properly perform oral hygiene to thereby limit the build-up of dental plaque or biofilm to the extent possible during treatment.
In any case, due to the almost inevitable occurrence of mucositis, mechanical oral hygiene will be more complicated, and for this purpose chemical plaque control methods with antiseptics may be used. The most important is chlorhexidine, a broad-spectrum antiseptic, bactericide and fungicide with a substantivity of up to 12 hours.
Likewise, it has been demonstrated that by adding another antiseptic, such as cetylpyridinium chloride, synergy between the two compounds is produced and the product’s final effectiveness increases both in vitro and in vivo. This is the case of Perio·Aid®, which also does not contain alcohol and so it does not dry the mucosa, a crucial advantage for these patients.
Multiple scientific studies have shown that Perio·Aid® is equally effective for the microbiological control of periodontopathogenic bacterial species during radiation therapy, as well as for controlling any overgrowth of opportunistic species such as Candida sp. It may also be useful for treating osteonecrosis of the jaw caused by intravenous therapies with bisphosphonates.
When treating chemotherapy-induced ulcers, the application of a bioadhesive gel with chlorhexidine, hyaluronic acid and panthenol, such as Perio·Aid® Bioadhesive Gel, may help improve healing and reduce pain.
Another of the most common complications in patients receiving treatment for cancer is xerostomia, or dry mouth, which can greatly impact quality of life. To relieve xerostomia symptoms and stimulate natural saliva production, the DENTAID® Xeros formula was developed, incorporating amongst other compounds, malic acid, a sialagogue or stimulator of saliva production; xylitol, which also stimulates saliva production and has an anti-caries effect; and betaine, a moisturising and lubricating agent.
Additionally, the saliva’s own antibacterial activity confers even greater importance to the need for stimulation of natural saliva secretion, rather than replacing it with saliva substitutes whose protection is nowhere near that provided by the components in natural saliva.
The effectiveness of the DENTAID® Xeros formula has been proven by many studies. A recent research study tested the capacity for saliva stimulation of the tablets, and it was suggested that they could have an anti-erosion effect by remineralising the teeth with fluoride.
In another study performed with elderly xerostomia patients, it was also shown that DENTAID® Xeros spray is able to increase the rate of both natural and stimulated saliva production. Moreover, DENTAID® Xeros oral hygiene products do not contain the detergent sodium lauryl sulfate, which can act as an irritant in these patients.
18 Mar 2021
After a year of the COVID-19 pandemic and coinciding with World Oral Health Day, DENTAID highlights the importance of taking care of the mouth for…
22 Dec 2020
IrsiCaixa research staff, in collaboration with DENTAID Research Center, demonstrates that cetylpyridinium chloride (CPC), a chemical component…
Sign up for the DENTAID Expertise newsletter
Sign up for the newsletter
|Data controller||DENTAID, S.L. LABORATORIOS DE PREVENCIÓN E HIGIENE BUCAL, SLU (“PHB”).|
|Purpose of data processing||To respond to a query from the interested party with the advice of a specialist.|
|Legitimisation of data processing||Your consent to process your personal data.|
|Recipients of disclosure or transfer||Data is not disclosed or transferred internationally.|
|Rights of the interested persons||To access, rectify and delete their data, and to exercise other rights as set out in the additional information.|
|Additional information||You can consult additional and detailed information on data protection at this link.|
The content shown below corresponds to Spain and to products sold under country-specific registration.OK